Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Citius Pharmaceuticals Inc

CTXR
Current price
2.79 USD -0.07 USD (-2.45%)
Last closed 2.86 USD
ISIN US17322U2078
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 87 145 592 USD
Yield for 12 month -85.79 %
1Y
3Y
5Y
10Y
15Y
CTXR
21.11.2021 - 28.11.2021

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA approved product, is a targeted immunotherapy for an initial indication in the treatment of cutaneous T-cell lymphoma. Its late-stage pipeline includes Mino-Lok, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections; and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. The Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido completed. The company was founded in 2007 and is headquartered in Cranford, New Jersey. Address: 11 Commerce Drive, Cranford, NJ, United States, 07016

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.67 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-194 316 USD

Last Year

-179 677 USD

Current Quarter

-52 848 USD

Last Quarter

-52 070 USD

Key Figures CTXR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -41 067 916 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -24.74 %
PEG Ratio
Return On Equity TTM -41.49 %
Wall Street Target Price 4.67 USD
Revenue TTM
Book Value 0.47 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.24 USD
Diluted Eps TTM -0.24 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CTXR

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CTXR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 09.06.2017
Dividend Date 09.06.2017

Stock Valuation CTXR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 9.1324
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -2.7425
Price Book MRQ 0.3174

Financials CTXR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CTXR

For 52 weeks

2.55 USD 26.75 USD
50 Day MA 0.45 USD
Shares Short Prior Month 11 787 635
200 Day MA 0.66 USD
Short Ratio 13.22
Shares Short 13 446 411
Short Percent 7 %